Merck & Co., Inc.
Holdings as of Sep 30, 2026 · filed Nov 13, 2026
| # | Holding | Value | % Port. | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Moderna Inc | $444488148 | 54.18% | — | Held |
| 2 | Personalis Inc | $228651672 | 27.87% | — | Held |
| 3 | Kymera Therapeutics Inc | $86320325 | 10.52% | — | Held |
| 4 | Aktis Oncology Inc | $18551873 | 2.26% | — | Held |
| 5 | Eikon Therapeutics Inc | $13399995 | 1.63% | — | Held |
| 6 | Entrada Therapeutics Inc | $11047527 | 1.35% | — | Held |
| 7 | Alector Inc | $6559581 | 0.80% | — | Held |
| 8 | Sutro Biopharma Inc | $4387575 | 0.53% | — | Held |
| 9 | Evaxion As | $3982333 | 0.49% | — | Held |
| 10 | Viridian Therapeutics Inc | $1923394 | 0.23% | — | Held |
| 11 | Xilio Therapeutics Inc | $959137 | 0.12% | — | Held |
| 12 | Tuhura Biosciences Inc | $40834 | 0.00% | — | Held |
| 13 | Neuphoria Therapeutics Inc | $35696 | 0.00% | — | Held |
Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.